Jubilant Pharmova Limited

Annual Report 2021-22

Leading

across global markets

People

Manufacturing

R&D

Business Excellence Supply Chain

Jubilant Pharmova Limited

Contents

Board of Directors

02

Senior Leadership Team

03

Chairmen's Message

04

Management Discussion and Analysis

08

Directors' Report

62

Report on Corporate Governance

84

Business Responsibility Report

112

Financial Statements

125

Independent Auditor's Report

Balance Sheet

132

Statement of Profit and Loss

133

Statement of Changes in Equity

134

Statement of Cash Flows

136

Notes to the financial statements

138

Independent Auditor's Report

190

Consolidated Balance Sheet

198

Consolidated Statement of Profit and Loss

200

Consolidated Statement of Changes in Equity

202

Consolidated Statement of Cash Flows

204

Notes to the consolidated financial statements

206

Corporate Information

282

Board of Directors

Annual Report 2021-22

Board of Directors

Shyam S. Bhartia

Hari S. Bhartia

Chairman

Co-Chairman and Managing Director

S. Sridhar

Sudha Pillai

Dr. Ashok Misra

Sushil Kumar Roongta

Independent Director

Independent Director

Independent Director

Independent Director

Vivek Mehra

Arun Seth

Priyavrat Bhartia

Arjun Shanker Bhartia

Independent Director

Independent Director

Director

Director

Arvind Chokhany

R. Kumar

Group Chief Financial Officer

Whole-time Director

and Whole-time Director

2

Jubilant Pharmova Limited

SeniorLeadership Team

Shyam S. Bhartia

Hari S. Bhartia

Chairman

Co-Chairman and Managing Director

42 years of industry experience in pharma,

36 years of industry experience in pharma, specialty

specialty chemicals, foods, oil and gas,

chemicals, foods, oil and gas, aerospace and IT

aerospace and IT

Arvind Chokhany

Rohini Seth

Group Chief Financial Officer and

Chief Human

Whole-time Director

Resources Officer

26 years of industry experience

27 years of industry experience

Pramod Yadav

Dr. Syed Kazmi

Giuliano Perfetti

CEO -

President & CEO -

CEO - CRDMO

Jubilant Pharma

Jubilant Therapeutics Inc.

(Jubilant Biosys Limited and APIs & CDMO)

35 years of industry experience

29 years of industry experience

22 years of industry experience

3

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Jubilant Pharmova Ltd. published this content on 03 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 September 2022 11:49:02 UTC.